Referral to an Extracorporeal Membrane Oxygenation Center and Mortality Among Patients With Severe 2009 Influenza A(H1N1)
Context Extracorporeal membrane oxygenation (ECMO) can support gas exchange in patients with severe acute respiratory distress syndrome (ARDS), but its role has remained controversial. ECMO was used to treat patients with ARDS during the 2009 influenza A(H1N1) pandemic.
Objective To compare the hospital mortality of patients with H1N1-related ARDS referred, accepted, and transferred for ECMO with matched patients who were not referred for ECMO.
The authors acknowledge the support of NHS Specialised Services of the UK Department of Health for supporting increased capacity to provide extracorporeal membrane oxygenation (ECMO) for adult patients during the 2009 influenza A(H1N1) pandemic and are indebted to the relevant staff at all of the hospitals participating in the SwiFT study.